Growing evidence of vitamin K benefits for heart health

Publicly released:
Australia; WA
People with the highest intakes of vitamin K1 (found in green leafy vegetables) were 21 percent less likely to be hospitalised with cardiovascular disease related to atherosclerosis.
People with the highest intakes of vitamin K1 (found in green leafy vegetables) were 21 percent less likely to be hospitalised with cardiovascular disease related to atherosclerosis.

New Edith Cowan University (ECU) research has found that people who eat a diet rich in vitamin K have up to a 34 percent lower risk of atherosclerosis-related cardiovascular disease (conditions affecting the heart or blood vessels).

Media release

From:

New Edith Cowan University (ECU) research has found that people who eat a diet rich in vitamin K have up to a 34 percent lower risk of atherosclerosis-related cardiovascular disease (conditions affecting the heart or blood vessels).

Researchers examined data from more than 50,000 people taking part in the Danish Diet, Cancer, and Health study over a 23-year period. They investigated whether people who ate more foods containing vitamin K had a lower risk of cardiovascular disease related to atherosclerosis (plaque build-up in the arteries).

There are two types of vitamin K found in foods we eat: vitamin K1 comes primarily from green leafy vegetables and vegetable oils while vitamin K2 is found in meat, eggs and fermented foods such as cheese.

The study found that people with the highest intakes of vitamin K1 were 21 percent less likely to be hospitalised with cardiovascular disease related to atherosclerosis.

For vitamin K2, the risk of being hospitalised was 14 percent lower.

This lower risk was seen for all types of heart disease related to atherosclerosis, particularly for peripheral artery disease at 34 percent.

ECU researcher and senior author on the study Dr Nicola Bondonno said the findings suggest that consuming more vitamin K may be important for protection against atherosclerosis and subsequent cardiovascular disease.

“Current dietary guidelines for the consumption of vitamin K are generally only based on the amount of vitamin K1 a person should consume to ensure that their blood can coagulate,” she said.

“However, there is growing evidence that intakes of vitamin K above the current guidelines can afford further protection against the development of other diseases, such as atherosclerosis.

“Although more research is needed to fully understand the process, we believe that vitamin K works by protecting against the calcium build-up in the major arteries of the body leading to vascular calcification.”

University of Western Australia researcher Dr Jamie Bellinge, the first author on the study, said the role of vitamin K in cardiovascular health and particularly in vascular calcification is an area of research offering promising hope for the future.

“Cardiovascular disease remains a leading cause of death in Australia and there’s still a limited understanding of the importance of different vitamins found in food and their effect on heart attacks, strokes and peripheral artery disease,” Dr Bellinge said.

“These findings shed light on the potentially important effect that vitamin K has on the killer disease and reinforces the importance of a healthy diet in preventing it.”

Next steps in the research

Dr Bondonno said that while databases on the vitamin K1 content of foods are very comprehensive, there is currently much less data on the vitamin K2 content of foods. Furthermore, there are 10 forms of vitamin K2 found in our diet and each of these may be absorbed and act differently within our bodies.

“The next phase of the research will involve developing and improving databases on the vitamin K2 content of foods.

“More research into the different dietary sources and effects of different types of vitamin K2 is a priority,” Dr Bondonno said.

Additionally, there is a need for an Australian database on the vitamin K content of Australian foods (e.g. vegemite and kangaroo).

To address this need, Dr Marc Sim, a collaborator on the study, has just finished developing an Australian database on the vitamin K content of foods which will be published soon.

The paper ‘Vitamin K intake and atherosclerotic cardiovascular disease in the Danish Diet Cancer and Health Study’ was published in the Journal of the American Heart Association. The research is part of ECU’s Institute of Nutrition Research.

It was a collaboration with researchers from the University of Western Australia, Royal Perth Hospital, Herlev & Gentofte University Hospital in Denmark and the Danish Cancer Society Research Centre.

The Institute for Nutrition Research was established as an ECU Strategic Research Institute in 2020. Find out more about their work.

- ends -

Journal/
conference:
Journal of the American Heart Association
Research:Paper
Organisation/s: Edith Cowan University, The University of Western Australia
Funder: The Danish Diet, Cancer, and Health Study was funded by the Danish Cancer Society, Denmark. Dr Dalgaard is funded by the Danish Heart Foundation (grant number 17‐R115‐A7443‐22062; https://hjerteforeningen.dk/) and Gangstedfonden (grant number A35136; http://www.gangstedfonden.dk/), Denmark. Dr Bondonno is funded by a National Health and Medical Research Council Early Career Fellowship (grant number APP1159914; https://www.nhmrc.gov.au/), Australia. The salary of Dr Lewis is supported by a National Heart Foundation of Australia Future Leader Fellowship (ID: 102817; https://www.heartfoundation.org.au/). The salary of Dr Hodgson is supported by a National Health and Medical Research Council of Australia Senior Research Fellowship (Grant number APP1116937; https://www.nhmrc.gov.au/). J.W. Bellinge is supported by an Australian Government Research Training Program Scholarship at the University of Western Australia (https://www.education.gov.au/research‐training‐program). E. Connolly is supported by an Australian Government Research Training Program Scholarship at Edith Cowan University (https://www.education.gov.au/research‐training‐program). Dr Blekkenhorst is supported by a National Health and Medical Research Council of Australia Emerging Leadership Investigator Grant (ID: 1172987; https://www.nhmrc.gov.au/) and a National Heart Foundation of Australia Post‐Doctoral Research Fellowship (ID: 102498; https://www.heartfoundation.org.au/). This study was supported by the Raine Medical Research Foundation and the Healy Medical Research Foundation (RCA06‐20). The funders had no role in the design of the study, collection, analysis, or interpretation of the data.
Media Contact/s
Contact details are only visible to registered journalists.